| Literature DB >> 29140242 |
Maria Lucia Brito Ferreira1, Carlos Alexandre Antunes de Brito2, Álvaro José Porto Moreira1, Maria Íris de Morais Machado1, Adélia Henriques-Souza3, Marli Tenório Cordeiro4, Ernesto Torres de Azevedo Marques4, Lindomar José Pena4.
Abstract
Zika virus (ZIKV) emerged in Brazil in 2015, which was followed by an increase of Guillain-Barre Syndrome (GBS) cases. We report the epidemiological, clinical, and laboratory findings of the first six neurological cases associated with ZIKV in Brazil seen in a reference neurology hospital in Pernambuco, Brazil. In all cases, ZIKV was detected in serum and/or cerebrospinal fluid (CSF) samples. In this case series, four cases were defined as GBS, one as acute disseminated encephalomyelitis (ADEM) and the other as encephalitis. ZIKV was detected in all cases by RT-PCR and virus isolation was successful in two patients. The time between ZIKV acute symptoms and the development of neurological manifestations varied from 3 to 13 days and ZIKV was detected between 15 and 34 days after the initial symptoms. Our results highlight the need to include ZIKV as a differential diagnosis for neurological syndromes in countries with circulation of this arbovirus. Because the viremia in these patients appears to persist longer, direct diagnostic techniques such as RT-PCR and viral isolation should be considered even if it is after the acute phase of viral infection.Entities:
Mesh:
Substances:
Year: 2017 PMID: 29140242 PMCID: PMC5817749 DOI: 10.4269/ajtmh.17-0106
Source DB: PubMed Journal: Am J Trop Med Hyg ISSN: 0002-9637 Impact factor: 2.345